Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates

Efficacy of Ceftolozane/Tazobactam in combination with Colistin against Extensively drug-resistant Pseudomonas aeruginosa including High Risk Clones in an In Vitro Pharmacodynamic Model

(2020) María Montero et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ARGONAUT II - In vitro activity of plazomicin against carbapenemase-producing Klebsiella pneumoniae

(2020) Michael R. Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection of the emergence of mcr-1–mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae through a hospital-based surveillance in an oncology center in eastern India

(2020) Samadrita Roy et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: Clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump

(2020) Sharmi Naha et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains

(2020) Fatma Erdem et al.   Antimicrobial Resistance and Infection Control

Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae

(2019) Niranjana Sri Sundaramoorthy et al.   AMB Express

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

(2019) Irene Galani et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Evaluation of the bactericidal activity of fosfomycin in combination with selected antimicrobial comparison agents when tested against gram-negative bacterial strains using time-kill curves

(2019) Robert K. Flamm et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The emergence of mcr-1-mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae in domestic and imported turkey meat in the Czech Republic 2017–2018

(2019) Tereza Gelbicova et al.   FOLIA MICROBIOLOGICA

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

(2019) Sandra Mikhail et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology of Multidrug-Resistant Klebsiella pneumoniae Isolates in a Brazilian Tertiary Hospital

(2019) Jussara Kasuko Palmeiro et al.   Frontiers in Microbiology

Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance

(2019) Jessica Carpenter et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Antimicrobial Susceptibility Differences Between Carbapenem-Resistant KPC-2-Producing and NDM-1-Producing Klebsiella pneumoniae in a Teaching Hospital in Northeast China

(2019) Lin Lin et al.   Microbial Drug Resistance

Development of real-time PCR assay allowed describing the first clinical Klebsiella pneumoniae isolate harboring plasmid-mediated colistin resistance mcr-8 gene in Algeria

(2019) Larbi Zakaria Nabti et al.   Journal of Global Antimicrobial Resistance

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro

(2019) Lan Yu et al.   Frontiers in Cellular and Infection Microbiology

Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria

(2018) Sophie A Baron et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand

(2018) Warawan Eiamphungporn et al.   Journal of Global Antimicrobial Resistance

Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance

(2018) Rym Lalaoui et al.   Microbial Drug Resistance

In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran

(2018) Raziyeh Kheshti et al.   Infection and Drug Resistance

Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum β-lactamases causing ventilator-associated pneumonia in China

(2018) Hui Xu et al.   Infection and Drug Resistance

Efflux mediated colistin resistance in diverse clones of Klebsiella pneumoniae from aquatic environment

(2017) Santosh Kumar Singh et al.   MICROBIAL PATHOGENESIS

Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria

(2016) Wentao Ni et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread

(2015) V. Weterings et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study

(2014) Abiola Olumuyiwa Olaitan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

KpnEF, a New Member of the Klebsiella pneumoniae Cell Envelope Stress Response Regulon, Is an SMR-Type Efflux Pump Involved in Broad-Spectrum Antimicrobial Resistance

(2013) Vijaya Bharathi Srinivasan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Outbreak of Colistin-Resistant, Carbapenem-ResistantKlebsiella pneumoniaein Metropolitan Detroit, Michigan

(2010) Dror Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY